Belite Bio, Inc
BLTE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,926,972 | $1,216,630 | $602,194 | $255,169 |
| - Cash | $31,677 | $88,157 | $42,089 | $17,344 |
| + Debt | $537 | $886 | $866 | $31,806 |
| Enterprise Value | $1,895,832 | $1,129,359 | $560,971 | $269,631 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$35,669 | -$31,199 | -$12,434 | -$9,636 |
| % Margin | – | – | – | – |
| Net Income | -$36,144 | -$31,632 | -$12,648 | -$9,666 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.18 | -1.19 | -0.63 | -0.4 |
| % Growth | 0.8% | -88.9% | -57.5% | – |
| Operating Cash Flow | -$29,234 | -$29,837 | -$11,458 | -$7,474 |
| Capital Expenditures | -$151 | -$63 | -$394 | -$74 |
| Free Cash Flow | -$29,385 | -$29,900 | -$11,852 | -$7,548 |